Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1876 |
Trillium Asset Management
Boston,
Massachusetts
| $0 | -$219K | 0 | – | Closed |
|
| 1877 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
| $0 | -$274K | 0 | – | Closed |
|
| 1878 |
Voleon Capital Management
Berkeley,
California
| $0 | -$1.81M | 0 | – | Closed |
|
| 1879 |
W
WealthOne
Albany,
New York
| $0 | -$5K | 0 | – | Closed |
|
| 1880 |
Wealthspire Advisors (New York)
New York
| $0 | -$97K | 0 | – | Closed |
|
| 1881 |
WDL
Well Done LLC
Holland,
Michigan
| $0 | -$6K | 0 | – | Closed |
|
| 1882 |
WCA
Windsor Creek Advisors
Bethel,
Vermont
| $0 | -$744K | 0 | – | Closed |
|
| 1883 |
ZP
Zimmer Partners
New York
| $0 | -$337K | 0 | – | Closed |
|